Skip to main content

Monday 4 October

08:00–10:30 Proton beam therapy (PBT)
Chair: Dr Shermaine Pan

In this two–hour educational session, we will be providing an overview of the NHS England PBT service. This session is designed for all Clinical Oncologists, who are and will be referrers to know of:

  • the current scope of commissioned indications, as well as considerations and challenges when PBT is used
  • the future with clinical trials and building real-world data

It will also be an interactive session with opportunity for you, as audience to be the expert ‘proton panel’, deciding on whether a case should be treated with protons.

Learning objectives:

  1. Know of the pathway and current scope of commissioned indications for the NHS England PBT service
  2. Identify the potential challenges and uncertainties with PBT treatment
  3. Recognise the future developments in building an evidence–based PBT service with clinical trials and real–world data

12:30–13:30 Cyclotron Trust symposium
Chairs: Dr Ed Smith and Dr Yen Chang

Details to follow. 

17:30–20:00 Horizon scanning: stereotactic ablative radiotherapy (SABR) for oligometastatic disease - next steps
Chair: Dr Ganesh Radhakrishna

This session will look at upcoming developments that are likely to impact on our clinical practice. We will look at upcoming trials, principles behind the interaction between immune-oncology and SABR, and the utility and challenges of multi-site SABR. We will have an expert panel discussion on case scenarios at the end to contextualise these advances in a clinical practice.

 Learning objectives:

  1. Highlight the trials in development and in progress in the UK
  2. Awareness of interaction between I–O and SABR
  3. Recognise the utility and challenges of multi-site oligomet SABR

Tuesday 5 October

Central nervous system (CNS) cancer: update on standard of care and the use of proton beam therapy
Chair: Professor Susan Short

This session is formed of two-parts, therefore if you register for one session, you will be automatically registered for the second. The combined fee is £25. 

08:00–10:00 Lectures
18:00–20:00 Planning and Q&A 

This session will provide you with the opportunity to get some hands-on outlining experience. Cases will be shared ahead of the live session for you to contour and submit.

Learning objectives:

  1. Understand the current application of molecular pathology to management decisions in primary CNS tumours
  2. Be able to describe side effects of standard of care chemotherapy and radiotherapy
  3. Know the indications for proton beam treatment in adults
  4. Be able to contour all relevant organs at risk for proton and photon planning

Wednesday 6 October

Pelvis including stereotactic ablative radiotherapy (SABR)
Chairs: Dr Alexandra Taylor, Dr Rebecca Muirhead and Dr Louise Murray 

This session is formed of two-parts, therefore if you register for one session, you will be automatically registered for the second. The combined fee is £25. You will be sent pre-course work relating to the outlining session in advance of the conference. 

08:00–10:00 Lectures - Pelvis: Challenges of pelvic recurrence following radiotherapy

This will be an interactive session discussing management options for recurrent pelvic disease following prior radiotherapy, including urological, GI and gynaecological tumours. This will include re-irradiation options including SABR, brachytherapy and combined approaches with surgery.

18:00–20:00 Outlining workshop 

The contouring workshop will focus on stereotactic radiotherapy for pelvic recurrence, including lymph node, pelvic sidewall and bone metastases. Participants will contour cases in advance and there will be interactive discussion of target volume definition and planning for SABR treatment.

12:30–13:30 Best practice in caring for lesbian, gay, bisexual, transgender, queer or questioning (LGBTQ+) patients who have cancer
Chairs: Dr Daniel Saunders and Dr Alison Berner

Literature suggests that lesbian, gay, bisexual, transgender, queer or questioning (LGBTQ+) patients continue to experience inequalities with regard to cancer care. There are approximately 3.6million people in the UK who identify as LGBTQ+. Some LGBTQ+ patient groups have higher cancer risk factors, e.g. tobacco consumption, there can be complex competing comorbidities such as anxiety and depression, plus for some particular patient groups there can be very specific issues to consider such as in managing sex–associated cancers in transgender patients. Finally, LGBTQ+ patients are not a homogenous group, and a person–centred approach is required, with particular consideration of intersectionality. This session aims to help clinicians understand how they personally can approach providing better care for this group of patients.

Learning objectives:

  1. Understanding LGBTQ+ identities and language
  2. Develop an understanding of the support needs of LGBTQ+ patients undergoing cancer treatment
  3. Consider circumstances when specific advice may be required to tailor cancer treatment to a patients’ individual circumstances

Thursday 7 October

08:00–10:00 Clinical oncology: The global impact of COVID-19 – an update two years on
Chair: Dr Kheng Yeoh

  1. Appreciate the impact of COVID-19 on cancer services and training globally
  2. ​​​Highlight the need to re-purpose and multi-purpose several of healthcare and oncology facilities and staff during the pandemic
  3. Underscore the importance of priority setting and rationalisation of healthcare provision during the pandemic with a focus on oncology

12:30–13:30 Update of The Royal College of Radiologists (RCR) radiotherapy consent forms
Chairs: Dr Tom Roques and Dr Emma Kenney-Herbert

An informative session to provide information on the rationale for national standard radiotherapy consent forms, information on how the forms were developed as well as how we are responding to feedback and how the project will be taken forward over the next year.

Learning objectives:

  1. An understanding of the rationale for national standard consent forms
  2. Understanding the process of development of national standard consent forms

18:00-19:00 George Edelstyn plenary lecture: Improving cancer survival in the UK - the importance of earlier diagnosis and better treatment
Chairs: Dr Jeanette Dickson and Dr Hannah Tharmalingam

Speaker: Professor Sir Mike Richards, Chair of independent review of diagnostic services in the NHS (2020) and previous National Cancer Director (1999-2013)


Friday 8 October

08:00–10:00 Stereotactic ablative radiotherapy (SABR) overview for trainees – liver, lung and bone  
Chair: Dr Fiona Wilson

This session will focus on SABR for liver, lung and bone and is aimed at clinical oncology trainees. The expert speakers will discuss the main indications for these treatments, the pre-treatment considerations and an approach to contouring the target volumes, as well as SABR planning and on treatment imaging.  

Learning objectives:

  1. Overview of indications for SABR for liver, lung and bone
  2. Develop an understanding of pre–treatment considerations including set-up 
  3. Describe the approach to contouring, planning considerations, dose and fractionation and verification 

18:00–20:00 Approach to reirradiation for the trainee  
Chair: Professor Peter Hoskin

Advances in cancer treatment have resulted patients living longer, increasing the rate of recurrences as well as second malignancies in a previously irradiated area.  Technical advances in radiotherapy have made re–irradiation an option for many tumour sites however patient selection remains challenging. This session will cover the key principles when considering reirradiation, discuss some of the available evidence and allow trainees to develop a general approach to reirradiation for their clinical practice.

Learning objectives:

  1. Develop an understanding of the principles of reirradiation in the context of modern clinical oncology practice 
  2. Improve knowledge of the evidence base for reirradiation and how to apply this to your patients

See details of the cross faculty week programme 
See details of the radiology week programme 
Download the full programme

Detected timezone